Composition
- Active ingredients
- LINVOSELTAMAB-GCPT 5MG/2ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761400.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lynozyfic
- Active substance
- linvoseltamab-gcpt
- Route
- Injection
- Dosage form
- Solution
- Applicant
- Rengeneron Pharmaceuticals, Inc.
- Status
- Prescription
- FDA approval
- 2 Jul 2025
- Application
- BLA761400-001